# Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis

> **NCT04620772** · PHASE2,PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Tuberculosis
- Tubercular Meningitis
- Arachnoiditis; Tuberculous (Etiology)

## Interventions

- **DRUG:** Cyclophosphamide injection

## Key facts

- **NCT ID:** NCT04620772
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04620772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04620772, "Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04620772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*